KALA BIO, INC. Operating Lease Cost
KALA BIO, INC. (KALA) reported Operating Lease Cost of $546.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-04-15
- KALA BIO, INC. operating lease, cost for the quarter ending 2025-12-31 was $99.00K, a 33.56% decline year-over-year.
- KALA BIO, INC. operating lease, cost for the quarter ending 2025-09-30 was $149.00K, a 0.00% change year-over-year.
- KALA BIO, INC. operating lease, cost for the quarter ending 2025-06-30 was $149.00K, a 0.00% change year-over-year.
- KALA BIO, INC. operating lease, cost for the quarter ending 2025-03-31 was $149.00K, a 0.00% change year-over-year.
- KALA BIO, INC. operating lease, cost for fiscal 2025 was $546.00K, a 8.39% decline from fiscal 2024.
- KALA BIO, INC. operating lease, cost for fiscal 2024 was $596.00K, a 89.81% increase from fiscal 2023.
- KALA BIO, INC. operating lease, cost for fiscal 2023 was $314.00K, a 24.15% decline from fiscal 2022.
- KALA BIO, INC. operating lease, cost for fiscal 2022 was $414.00K, a 89.17% decline from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $248.00K derived: sum of 2 quarters · filed 2026-04-15 | $397.00K derived: sum of 3 quarters · filed 2026-04-15 | $546.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $149.00K 10-Q · filed 2025-11-19 | $298.00K derived: sum of 2 quarters · filed 2025-11-19 | $447.00K 10-Q · filed 2025-11-19 | $596.00K derived: sum of 4 quarters · filed 2026-04-15 |
| 2025-06-30 | $149.00K 10-Q · filed 2025-08-08 | $298.00K 10-Q · filed 2025-08-08 | $447.00K derived: sum of 3 quarters · filed 2026-04-15 | $596.00K derived: sum of 4 quarters · filed 2026-04-15 |
| 2025-03-31 | $149.00K 10-Q · filed 2025-05-14 | $298.00K derived: sum of 2 quarters · filed 2026-04-15 | $447.00K derived: sum of 3 quarters · filed 2026-04-15 | $596.00K derived: sum of 4 quarters · filed 2026-04-15 |
| 2024-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $298.00K derived: sum of 2 quarters · filed 2026-04-15 | $447.00K derived: sum of 3 quarters · filed 2026-04-15 | $596.00K 10-K · filed 2026-04-15 |
| 2024-09-30 | $149.00K 10-Q · filed 2025-11-19 | $298.00K derived: sum of 2 quarters · filed 2025-11-19 | $447.00K 10-Q · filed 2025-11-19 | $596.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $149.00K 10-Q · filed 2025-08-08 | $298.00K 10-Q · filed 2025-08-08 | $447.00K derived: sum of 3 quarters · filed 2025-08-08 | $596.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $149.00K 10-Q · filed 2025-05-14 | $298.00K derived: sum of 2 quarters · filed 2025-05-14 | $447.00K derived: sum of 3 quarters · filed 2025-05-14 | $453.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $298.00K derived: sum of 2 quarters · filed 2025-03-31 | $304.00K derived: sum of 3 quarters · filed 2025-03-31 | $314.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $149.00K 10-Q · filed 2024-11-12 | $155.00K derived: sum of 2 quarters · filed 2024-11-12 | $165.00K 10-Q · filed 2024-11-12 | $175.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $6.00K 10-Q · filed 2024-08-06 | $16.00K 10-Q · filed 2024-08-06 | $26.00K derived: sum of 3 quarters · filed 2024-08-06 | $35.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $10.00K 10-Q · filed 2024-05-14 | $20.00K derived: sum of 2 quarters · filed 2024-05-14 | $29.00K derived: sum of 3 quarters · filed 2024-05-14 | $248.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $19.00K derived: sum of 2 quarters · filed 2024-03-29 | $238.00K derived: sum of 3 quarters · filed 2024-03-29 | $414.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $9.00K 10-Q · filed 2023-11-13 | $228.00K derived: sum of 2 quarters · filed 2023-11-13 | $404.00K 10-Q · filed 2023-11-13 | $476.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $219.00K 10-Q · filed 2023-08-04 | $395.00K 10-Q · filed 2023-08-04 | $467.00K derived: sum of 3 quarters · filed 2023-08-04 | $1.73M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $176.00K 10-Q · filed 2023-05-09 | $248.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.51M derived: sum of 3 quarters · filed 2023-05-09 | $2.78M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $1.34M derived: sum of 2 quarters · filed 2023-03-03 | $2.61M derived: sum of 3 quarters · filed 2023-03-03 | $3.82M 10-K · filed 2023-03-03 |
| 2021-09-30 | $1.27M 10-Q · filed 2022-11-08 | $2.53M derived: sum of 2 quarters · filed 2022-11-08 | $3.75M 10-Q · filed 2022-11-08 | $4.93M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.27M 10-Q · filed 2022-08-11 | $2.48M 10-Q · filed 2022-08-11 | $3.67M derived: sum of 3 quarters · filed 2022-08-11 | $4.85M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.22M 10-Q · filed 2022-05-16 | $2.40M derived: sum of 2 quarters · filed 2022-05-16 | $3.59M derived: sum of 3 quarters · filed 2022-05-16 | $4.77M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $2.37M derived: sum of 2 quarters · filed 2022-03-29 | $3.56M derived: sum of 3 quarters · filed 2022-03-29 | $4.74M 10-K · filed 2022-03-29 |
| 2020-09-30 | $1.19M 10-Q · filed 2021-11-15 | $2.37M derived: sum of 2 quarters · filed 2021-11-15 | $3.56M 10-Q · filed 2021-11-15 | $4.74M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $1.19M 10-Q · filed 2021-08-05 | $2.37M 10-Q · filed 2021-08-05 | $3.56M derived: sum of 3 quarters · filed 2021-08-05 | $4.74M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $1.19M 10-Q · filed 2021-05-05 | $2.37M derived: sum of 2 quarters · filed 2021-05-05 | $3.56M derived: sum of 3 quarters · filed 2021-05-05 | $4.74M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.37M derived: sum of 2 quarters · filed 2021-02-25 | $3.56M derived: sum of 3 quarters · filed 2021-02-25 | $4.61M 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.19M 10-Q · filed 2020-11-05 | $2.37M derived: sum of 2 quarters · filed 2020-11-05 | $3.43M 10-Q · filed 2020-11-05 | $4.28M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $1.19M 10-Q · filed 2020-08-06 | $2.24M 10-Q · filed 2020-08-06 | $3.09M derived: sum of 3 quarters · filed 2020-08-06 | $3.19M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $1.10M 10-Q · filed 2020-05-07 | $1.91M derived: sum of 2 quarters · filed 2020-05-07 | $2.00M derived: sum of 3 quarters · filed 2020-05-07 | $2.10M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $803.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $902.00K derived: sum of 2 quarters · filed 2020-02-12 | $1.00M derived: sum of 3 quarters · filed 2020-02-12 | $1.10M 10-K · filed 2020-02-12 |
| 2018-09-30 | $99.00K 10-Q · filed 2019-11-07 | $198.00K derived: sum of 2 quarters · filed 2019-11-07 | $296.00K 10-Q · filed 2019-11-07 | $397.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $99.00K 10-Q · filed 2019-08-06 | $198.00K 10-Q · filed 2019-08-06 | $298.00K derived: sum of 3 quarters · filed 2019-08-06 | $397.00K derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $99.00K 10-Q · filed 2019-05-09 | $199.00K derived: sum of 2 quarters · filed 2019-05-09 | $298.00K derived: sum of 3 quarters · filed 2019-05-09 | $397.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $199.00K derived: sum of 2 quarters · filed 2019-03-12 | $298.00K derived: sum of 3 quarters · filed 2019-03-12 | $396.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $99.00K 10-Q · filed 2018-11-08 | $198.00K derived: sum of 2 quarters · filed 2018-11-08 | $296.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $99.00K 10-Q · filed 2018-08-09 | $196.00K 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $97.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |